Inferior spikes do this
Release time:
2020-08-14
Suppression of Inferior Spikes Do This
In the east corner of the production area of Spike Health Technology Company, there is a very inconspicuous building. From below, only a few pipes with uneven thickness can be seen on the top and the slogan "Emphasize Environmental Protection and Promote Sustainable Development" with red letters on the yellow bottom on the stainless steel guardrail. Walking up, you can only see a few closed pools and a small room, on the table in the small room are stacks of documents and testing tools such as test tubes and glass bottles. This is the peak and healthy sewage treatment station. The production sewage of the whole factory area is concentrated here. After adjustment (PH adjustment), pre-acidification, anaerobic, anoxic, aerobic (aeration), precipitation and other links, it is discharged into the pipe network after reaching the special discharge standard. Yin Zhiwu, executive deputy general manager of
Peak Health, said that since the sewage treatment station in Wucheng District has not been built, Peak Health cannot realize the discharge of pipes. However, relevant national laws have strict requirements on the discharge of water pollutants from the extracted pharmaceutical industry, and the discharge of sewage must reach the special discharge limit, the chemical oxygen demand (COD ) must be below 50 mg / L.
Equal emphasis on enterprise development and environmental protection has been the philosophy of Peak Health since its establishment. On the basis of the original environmental protection facilities, Jianfeng Health carried out technical renovation of waste gas collection and treatment facilities on the basis of the original environmental protection facilities. At the same time, a sealing cover was added to the sewage treatment station to realize the closed collection of waste gas. Since the trial operation of this facility 5 in mid-February, the overall effect has been obvious. The original treatment tank would emit an unpleasant smell during work, but now the smell has obviously decreased.
At the beginning of 2016 , according to the arrangement of the pharmaceutical company, the product development department moved to Qiubin factory, where the small and pilot tests of product research and development were carried out. For this reason, Qiubin Factory has carried out renovation and upgrading of sewage treatment facilities. The high-concentration waste liquid collected in the experiment is regularly sent to companies with relevant qualifications for treatment. The waste water generated by washing bottles and tanks at ordinary times enters the regulating tank for treatment through pipelines. The toxic and harmful gases produced during the experiment are also treated by the new waste gas treatment tower and discharged after meeting the atmospheric emission standards. According to the requirements of the environmental protection department, the sewage pipes of the whole plant have also been changed into open channels. "In the event of a leak in an underground pipe, it often takes a lot of time and effort to investigate, which is not conducive to regulation and will also extend the pollution control time. After the change to an open channel, all the pipes are clear at a glance, which can detect problems in a timely manner and also facilitate the supervision of environmental protection departments." Sheng Junyong, an environmental member of the production department of Qiubin Factory, explained the reason for the establishment of the open channel.
2015 , has inherent advantages in environmental protection. Each workshop is equipped with a pretreatment tank. The high-concentration sewage is discharged into the collection tank after pretreatment. After a series of treatment processes, it is discharged after reaching the third-level discharge standard and is included in the municipal sewage pipe network. There is also an emergency pool in the sewage treatment station. If the treated sewage does not meet the discharge standard or there is an emergency, the treated sewage will be discharged into the emergency pool first, and then returned to the collection pool for treatment before discharge.
PAC , PAM , ferrous sulfate and other chemicals to adjust the PH value of sewage, and the other part is the environmental protection bureau's pollution source online monitoring system. Zhang Baoping, deputy director of
700 tons. In terms of tail gas and solid waste treatment, Jinxi Pharmaceutical Factory has a tail gas incinerator and collection device, a special solid waste storage facility, and entrusts a unit with relevant qualifications to carry out regular treatment to avoid pollution to water and soil.
PH value detection on the outlet every day, and COD and other content detection - 2 times a week, ensure that sewage is discharged up to the standard; set up special personnel to be responsible for the investigation and supervision of environmental safety hazards, treatment and operation management of pollution treatment facilities, and conduct environmental protection assessment; organize relevant personnel to learn environmental protection related laws and regulations from time to time, so as to consciously abide by them in production and operation; sign safety and environmental protection responsibility letter every year, decompose and implement it to each team and individual, and clarify their respective responsibilities; implement clean production technology to reduce pollutant discharge, production arrangements to increase production volume, improve product yield, energy saving and consumption reduction.
, the Jinxi Pharmaceutical Factory project passed the environmental protection acceptance, and the two pharmaceutical factories of Qiubin and Jinxi passed the cleaner production review and environmental system certification, and the environmental protection facilities were operating normally. Every year, Jianfeng Pharmaceutical invests a lot of money in the renovation of environmental protection facilities and regular maintenance. The environmental behavior level of the enterprise has been rated as green (excellent environmental behavior) for several consecutive years. Jianfeng Health is also actively doing a good job in environmental protection acceptance, striving to complete the overall environmental protection acceptance before 10 this year.
V Water" in the first year of the year, and issued the "Action Plan for Eliminating Inferior Class V Water in Zhejiang Province". Six major projects have been deployed, including sewage interception and receiving pipes, river dredging, industrial regulation, agricultural and rural non-point source control, discharge port regulation, ecological water distribution and restoration, vowing to completely eliminate inferior V water in 2017 . Through various measures such as the investment of environmental protection equipment, the construction and implementation of daily environmental protection management system, Jianfeng Health and Jianfeng Pharmaceutical have ensured the long-term stable discharge of various pollutants up to the standard, and have used practical actions to help eliminate inferior V water. (Reporter Ni Yingzhen)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page